Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11589)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2018 (publication date) through Jul 8, 2025
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peng SY, Wang XA, Huang CY, Li JT, Hong DF, Wang YF, Xu B. Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus. World J Gastroenterol 2018; 24(40): 4527-4535 [PMID: 30386102 DOI: 10.3748/wjg.v24.i40.4527] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i40/4527.htm |
| Number | Citing Articles |
| 1 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|
| 2 |
Fangzhou Luo, Mengxia Li, Jun Ding, Shusen Zheng. The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.635731
|
| 3 |
Walaa Abdelhamed, Hend Shousha, Mohamed El-Kassas. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?. Liver Research 2024; 8(3): 141 doi: 10.1016/j.livres.2024.09.002
|
| 4 |
Haili Zhang, Hongwei Xu, Ningyuan Wen, Bo Li, Kefei Chen, Yonggang Wei. Short- and long-term outcomes following laparoscopic liver resection for hepatocellular carcinoma combined with type I/II portal vein tumor thrombus. Updates in Surgery 2025; 77(2): 427 doi: 10.1007/s13304-025-02065-9
|
| 5 |
Hongyan Shao, Juan Deng, Luping Xie, Qiwen Zheng, Bihui Zou, Jun Deng, Tianqi Zhang, Jingjing He. Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response. Journal of Cancer Research and Therapeutics 2022; 18(2): 560 doi: 10.4103/jcrt.jcrt_852_21
|
| 6 |
Zongrui Jin, Guolin Wu, Banghao Xu, Jilong Wang, Hai Zhu, Ya Guo, Minhao Peng, Tao Peng, Zhang Wen. Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.928452
|
| 7 |
Zebing Song, Hang Li, Hailong Chen, Bingqing Du, Zongbing Cheng, Zengyi Mo, Zejun Huang, Sihan Hu, Yujian Feng, Wujian Deng, Huihong Liang, Xuewei Yang, Xiaodong Song, Zili Shao. Evaluation of the efficacy and safety of combined surgery with intraoperative radiotherapy and postoperative PVC for hepatocellular carcinoma with mPVTT. European Journal of Surgical Oncology 2025; 51(7): 109727 doi: 10.1016/j.ejso.2025.109727
|
| 8 |
Yukun Zheng, Xiaoyi Wang, Xiaoliang Wang. High Ribonucleotide Reductase M2 Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Live Hepatocellular Carcinoma. Journal of Biomedical Nanotechnology 2023; 19(7): 1181 doi: 10.1166/jbn.2023.3622
|
| 9 |
Paschalis Gavriilidis, Timothy M Pawlik, Daniel Azoulay. Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives. Hepatobiliary & Pancreatic Diseases International 2024; 23(3): 221 doi: 10.1016/j.hbpd.2023.10.009
|
| 10 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 11 |
Jie Ji, Dandan Jin, Minxue Xu, Yujie Jiao, Yue Wu, Tong Wu, Renjie Lin, Wenjie Zheng, Zhaoxiu Liu, Feng Jiang, Yihui Fan, Mingbing Xiao. AKR1B1 promotes pancreatic cancer metastasis by regulating lysosome-guided exosome secretion. Nano Research 2022; 15(6): 5279 doi: 10.1007/s12274-022-4167-z
|
| 12 |
Yinming Zhong, Sicen Pan, Shunji Zhi, Yue Li, Zhiping Xiu, Changran Wei, Jiesi Luo. Construction and Investigation of circRNA-associated ceRNA Regulatory
Network in Molecular Subtypes of Breast Cancer. Current Computer-Aided Drug Design 2022; 18(3): 185 doi: 10.2174/1573409918666220615151614
|
| 13 |
Guang Sheng Zhao, Song Liu, Ying Liu, Chuang Li, Ruo Yu Wang, Jie Bian, Yue Wei Zhang, Jun Zhou, Ya Jie Lin, Jianlin Wu. Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study. Expert Review of Gastroenterology & Hepatology 2022; 16(7): 673 doi: 10.1080/17474124.2022.2091545
|
| 14 |
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, Vanessa Banz, Arndt Vogel, Grainne Mary O'Kane, Albert Chi-Yan Chan, Gonzalo Sapisochin. Precision surgery for hepatocellular carcinoma. The Lancet Gastroenterology & Hepatology 2025; 10(4): 350 doi: 10.1016/S2468-1253(24)00434-5
|
| 15 |
S. Li, J.-H. Guo, J. Lu, C. Wang, H. Wu, H. Wang, J. Zha, R. Fan. I125 irradiation stent for treatment of hepatocellular carcinoma with portal vein thrombosis: A meta-analysis. Cancer/Radiothérapie 2021; 25(4): 340 doi: 10.1016/j.canrad.2020.12.003
|
| 16 |
Yong Tan, Jian Yong Zhu, Jing Li, Li Ming Wu, Zaixing Ouyang, Wen Ying Liu, Hao Song, Cong Yun Huang. Application of 3-dimensional visualization and image fusion technology in liver cancer with portal vein tumor thrombus surgery. Medicine 2024; 103(30): e38980 doi: 10.1097/MD.0000000000038980
|
| 17 |
Lei Zhang, Bo Hu, Wei Li, Peng Huang, Shen Zhang, Bin-Yan Zhong, Cai-Fang Ni. 125I Irradiation Stent for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis: A Systematic Review. CardioVascular and Interventional Radiology 2020; 43(2): 196 doi: 10.1007/s00270-019-02346-y
|
| 18 |
Yuting Hu, Wei Qiu, Zhijun Kong, Siyuan Wu, Yi Liu, Chunfu Zhu, Xihu Qin, Aaron Bell. LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR‐597/FOSL2 Axis in Hepatocellular Carcinoma. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/3445970
|
| 19 |
Jian Zhao, Yu Xie. Progress in research of hepatocellular carcinoma with tumor thrombus. World Chinese Journal of Digestology 2019; 27(20): 1239 doi: 10.11569/wcjd.v27.i20.1239
|
| 20 |
Shuheng Bai, YinYing Wu, Yanli Yan, Rong Li, Haojing Kang, Jiangzhou Zhang, Wen Ma, Ying Gao, Beina Hui, Hailin Ma, Xiaozhi Zhang, Juan Ren. Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/1533033821995286
|
| 21 |
Tianyu Jiao, Haowen Tang, Wenwen Zhang, Bingyang Hu, Tao Wan, Yinbiao Cao, Ze Zhang, Yafei Wang, Junning Cao, Mengqiu Cui, Shichun Lu. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02291-1
|
| 22 |
Abdul Rehman Khan, Xuyong Wei, Xiao Xu. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides. Journal of Hepatocellular Carcinoma 2021; : 1089 doi: 10.2147/JHC.S318070
|
| 23 |
Kazuhiro Takahashi, Jaejeong Kim, Amane Takahashi, Shinji Hashimoto, Manami Doi, Kinji Furuya, Ryosuke Hashimoto, Yohei Owada, Koichi Ogawa, Yusuke Ohara, Yoshimasa Akashi, Katsuji Hisakura, Tsuyoshi Enomoto, Osamu Shimomura, Masayuki Noguchi, Tatsuya Oda. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report. World Journal of Hepatology 2021; 13(3): 384-392 doi: 10.4254/wjh.v13.i3.384
|
| 24 |
Jung Wan Choe, Hye Yoon Lee, Chai Hong Rim. Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?. World Journal of Gastroenterology 2022; 28(7): 704-714 doi: 10.3748/wjg.v28.i7.704
|
| 25 |
Tao Li, Yuanzi Yu, Juan Liu, Xiangguo Tian, Meng Kong, Lei Wu, Shaocan Tang, Shengqing Gu, Jingfang Zhao, Yi Cui, Jinhua Hu. PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0229-6
|
| 26 |
Xiaodong Song, Yong He, Huihong Liang, Menling Han, Zili Shao. INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus. BMC Surgery 2020; 20(1) doi: 10.1186/s12893-020-00836-2
|
| 27 |
Hao Sun, Bing Ma, Ning Sun, Han Bai, Xuejian Li, Chengshuo Zhang. Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis. Critical Reviews in Oncology/Hematology 2023; 189: 104083 doi: 10.1016/j.critrevonc.2023.104083
|